About ALPHAGAN

ALPHAGAN is a medication primarily used in the treatment of glaucoma and ocular hypertension. It contains the active ingredient BRIMONIDINE TARTRATE, an alpha-2 adrenergic agonist that reduces intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow. This mechanism of action helps to prevent damage to the optic nerve, which can lead to vision loss if left untreated.

Key Therapeutic Benefits

Reduces intraocular pressure in patients with glaucoma or ocular hypertension
Decreases the risk of vision loss and optic nerve damage
Can be used as a monotherapy or in combination with other intraocular pressure-lowering medications

Active Ingredient Mechanism

BRIMONIDINE TARTRATE, the active ingredient in ALPHAGAN, works by stimulating alpha-2 adrenergic receptors in the eye. This stimulation leads to a decrease in the amount of aqueous humor produced by the ciliary body and an increase in the outflow of aqueous humor through the uveoscleral pathway, resulting in lowered intraocular pressure.

Important Medical Note:

ALPHAGAN should only be used under the guidance of an ophthalmologist. Patients should be monitored for potential side effects, including conjunctival hyperemia, ocular pruritus, and allergic reactions. It is also important to follow the prescribed dosage and administration schedule to minimize the risk of adverse effects.